Seclazone, a heterocyclic compound, possesses anti-inflammatory, analgesic, antipyretic and diuretic properties. Seclazone is orally active.
In Vivo
Seclazone (220 mg/kg; p.o.; dietary, daily) inhibits the development of adjuvant-induced polyarthritis in rats . Seclazone significantly lowers the fever induced in rats by administration of a yeast suspension . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Charles River rats (150-170 g) Dosage: 220 mg/kg Administration: Oral administration, dietary, daily Result: Inhibited adjuvant-induced polyarthritis